): The objectives of the Immunology Program of Sloan-Kettering Institute (SKI) are to study the basic properties and functions of the immune systems, analyze its role in disease, and understand the relationship between cancer and the immune system. Lessons learned from these basic studies are applied in the treatment of cancer, infectious disease and in bone marrow transplantation. These objectives are attained using the contemporary tools of immunology, biochemistry and molecular biology. To pursue these objectives SKI has developed a strong group of investigators within the Immunology, Molecular Biology, Cell Biology, and Molecular Pharmacology Programs at SKI with primary interests in immunology who interact effectively. In its present form, SKI presents a highly suitable environment in multidisciplinary training with a special emphasis on immunology. Immunology is today at the center of biological research. The immune system represents a complex interaction array of cells and products whose unraveling represents an extremely challenging goal with rich rewards. Moreover, immunology provides the basis for a whole range of technologies for the analysis of problems in other disciplines with no direct connection to immunology. The scope of immunology at SKI represents a wide range of immunological projects with expertise. The main integrating areas of research in the Immunology Training Program are: Immunogenetics, Signal Transduction, Transplantation, Gene Therapy, and Cancer Immunology. Problems are explored in experimental and human systems using a wide variety of modern techniques and approaches. Trainees are exposed to a diverse and stimulating environment of scientific excellence, insuring their preparedness for future careers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009149-25
Application #
6362495
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
1976-07-01
Project End
2002-02-28
Budget Start
2001-03-01
Budget End
2002-02-28
Support Year
25
Fiscal Year
2001
Total Cost
$144,406
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Wipperman, Matthew F; Heaton, Brook E; Nautiyal, Astha et al. (2018) Mycobacterial Mutagenesis and Drug Resistance Are Controlled by Phosphorylation- and Cardiolipin-Mediated Inhibition of the RecA Coprotease. Mol Cell 72:152-161.e7
Lau, Colleen M; Sun, Joseph C (2018) The widening spectrum of immunological memory. Curr Opin Immunol 54:42-49
Lau, Colleen M; Adams, Nicholas M; Geary, Clair D et al. (2018) Epigenetic control of innate and adaptive immune memory. Nat Immunol 19:963-972
Madera, Sharline; Geary, Clair D; Lau, Colleen M et al. (2018) Cutting Edge: Divergent Requirement of T-Box Transcription Factors in Effector and Memory NK Cells. J Immunol 200:1977-1981
Adams, Nicholas M; Lau, Colleen M; Fan, Xiying et al. (2018) Transcription Factor IRF8 Orchestrates the Adaptive Natural Killer Cell Response. Immunity 48:1172-1182.e6
Geary, Clair D; Krishna, Chirag; Lau, Colleen M et al. (2018) Non-redundant ISGF3 Components Promote NK Cell Survival in an Auto-regulatory Manner during Viral Infection. Cell Rep 24:1949-1957.e6
Budhu, Sadna; Schaer, David A; Li, Yongbiao et al. (2017) Blockade of surface-bound TGF-? on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment. Sci Signal 10:
Yewdell, William T; Chaudhuri, Jayanta (2017) A transcriptional serenAID: the role of noncoding RNAs in class switch recombination. Int Immunol 29:183-196
Rapp, Moritz; Lau, Colleen M; Adams, Nicholas M et al. (2017) Core-binding factor ? and Runx transcription factors promote adaptive natural killer cell responses. Sci Immunol 2:
Yewdell, William T; Chaudhuri, Jayanta (2017) Molecular biology: RNA editing packs a one-two punch. Nature 542:420-421

Showing the most recent 10 out of 47 publications